Inspection Record

SGS Canada Inc. — Health Canada Inspection Findings

Health CanadaInspected 2023-06-20 6 findingsAseptic processing and sterility assuranceLaboratory and QC controlsDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

In areas where aseptic operations were performed, the frequency and the methods of monitoring were inadequate.

2Laboratory and QC controls

The design, equipment, and/or maintenance of the testing laboratory was inadequate.

3Laboratory and QC controls

The creation, maintenance, processing, and/or review of laboratory data was inadequate.

4Aseptic processing and sterility assurance

The company's cleaning of the premises and the equipment in aseptic areas was inadequate. Sterile disinfectants were not used in Grade A and B areas.

5Aseptic processing and sterility assurance

The operators'aseptic practices were inadequate to maintain sterility.

6Deviation, CAPA, and investigation

The validation of test methods was inadequate. Investigations into deviations, reports, and/or follow-up actions were inadequate. The handling of standard operating procedures for good manufacturing practices was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-06-20. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

SGS Canada Inc. findings history — including this company's other documentsAll Health Canada findings Health Canada documents, 2023 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.